Announcements Trials
Browse Landscape

Phase

Phase 4 4

Status

Recruiting 2Completed 2

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 3Other 1Genitourinary 1

Conditions

Prostatic Neoplasms 1Kidney Neoplasms 1Constipation 1Colorectal Neoplasms 1Colorectal Cancer Screening 1Colonic Neoplasms 1

Interventions

Cyclophosphamide 3162Cisplatin 3160Carboplatin 2938Paclitaxel 2673Radiotherapy 2648Gemcitabine 2547pembrolizumab 2331Docetaxel 2157Bevacizumab 2128Fluorouracil 1822Capecitabine 1784Oxaliplatin 1713Dexamethasone 1590Nivolumab 1517Doxorubicin 1477Rituximab 1454Etoposide 1342Magnetic Resonance Spectroscopy 1266Irinotecan 1235Leucovorin 1216Cytarabine 1123Pemetrexed 1062Drug Therapy 1062fludarabine 1050Vincristine 956Specimen Handling 936Prednisone 926Cetuximab 921Lenalidomide 916Trastuzumab 902

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × polyethylene glycol 3350 × Clear all
NCT07215000 2025-10-09

COOP SIT

Morehouse School of Medicine

Phase 4 Recruiting
300 enrolled
Gastrointestinal

Colorectal Cancer Screening

NCT05805436 2025-05-30

Preop Laxatives in Robotic Urologic Surgery

University of Iowa

Phase 4 Recruiting
240 enrolled
GenitourinaryOther

Constipation, Kidney Neoplasms, Prostatic Neoplasms

NCT01170754 2017-09-13

Miralax (PEG 3350) vs. Golytely as Bowel Preparation for Screening Colonoscopy

Temple University

Phase 4 Completed
136 enrolled 17 charts
Gastrointestinal

Colonic Neoplasms

NCT00626054 2016-04-13

PEG

Rabin Medical Center

Phase 4 Completed
400 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡